Názov | Neoplasma : journal of experimental and clinical oncology / Cancer Research Institute of the Slovak Academy of Sciences
|
---|
Roč., číslo | Vol. 52, no. 5, rok 2005
|
---|
ISSN | 0028-2685
|
---|
Fyz.popis | s. 361-434
|
---|
Súborný záznam | Neoplasma
|
---|
| Neoplasma
|
---|
Jazyk dok. | ---
|
---|
Počet ex. | 3, z toho voľných 0, prezenčne 1
|
---|
Báza dát | PERIODIKÁ - Prijaté čísla
|
---|
Obsah | A pilot study testing the genetic polymorphism of N-acetyltransferase 2 as a risk factor in lung cancer / / V. Habalová ... [et al.]
|
---|
| MHC class 1 chain-related gene A (MICA) polymorphism and the different histological types of cervical cancer / / J.R. Chen ... [et al.]
|
---|
| Pleural fluids associated with metastatic lung tumors are rich in progelatinase B/pro MMP-9 / / Jaromír Kotyza ... [et al.]
|
---|
| Characterization of drug-resistant neuroblastoma cell lines by comparative genomic hybrdization / / J. Bedrníček ... [et al.]
|
---|
| Cytotoxic activity of a podophyllotoxin-like lignan from Linum touricum Willd / / N. Vasilev ... [et al.]
|
---|
| Acute myeloid leukemia treatment in patients over 60 years of age. Comparison of symptomatic, palliative, and aggerssive therapy / / M. Doubek ... [et al.]
|
---|
| Ki-67 as a prognostic marker in colorectal cancer but not in gastric cancer / / C.T.F. Oshima, K. Iriya, N.M...
|
---|
| A significance of additional chromosomal aberrations and other variables on post transplantation outcome of patients with CMI / / V. Vranová ... [et al.]
|
---|
| Multivariante analyses of prognostic factors in acute myeloid leukemia: relevance of cytogenetic abnormalities and CD34 expression / / C. Junghanss ... [et al.]
|
---|
| Chemotherapy for acute myeloid leukemias with cytosine arabinoside, daunorubucin, etoposide and mitoxantrone may casue permanents oligoasthe.. / P. Lemež, V. Urbánek
|
---|
| Expression of the insulin receptor substrate 1 in primary tumors and lymph node metastases in breast cancer: correlations with BCL-xL and.. / M. Koda ... [et al.]
|
---|
| The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia / / J.M. Horáček ... [et al.]
|
---|
| Posttreatment plasma transforming growth factor beta 1 ( TGF-beta 1) level predicts for late morbidity in patients with advanced head and.. / D. Feltl ... [et al.]
|
---|
| Second primary tumors (SPT) of head and neck. Distinguishing of "true" SPT from micrometastasis by LOH analysis of selected chromosome.. / M. Giefing ... [et al.]
|
---|